Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Adipose-derived Mesenchymal Stem Cells for Tendon Disease
NCT03279796Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2018
- Primary completion
- Dec 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in rotator cuff tear, Lateral Epicondylitis (LET), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Status: unknown.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
rotator cuff tearLateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT03279796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03279796.